Literature DB >> 20562268

Understanding latent tuberculosis: a moving target.

Philana Ling Lin1, Joanne L Flynn.   

Abstract

Tuberculosis (TB) remains a threat to the health of people worldwide. Infection with Mycobacterium tuberculosis can result in active TB or, more commonly, latent infection. Latently infected persons, of which there are estimated to be approximately 2 billion in the world, represent an enormous reservoir of potential reactivation TB, which can spread to other people. The immunology of TB is complex and multifaceted. Identifying the immune mechanisms that lead to control of initial infection and prevent reactivation of latent infection is crucial to combating this disease.

Entities:  

Mesh:

Year:  2010        PMID: 20562268      PMCID: PMC3311959          DOI: 10.4049/jimmunol.0903856

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  120 in total

1.  Human IRGM induces autophagy to eliminate intracellular mycobacteria.

Authors:  Sudha B Singh; Alexander S Davis; Gregory A Taylor; Vojo Deretic
Journal:  Science       Date:  2006-08-03       Impact factor: 47.728

2.  Identification of nitric oxide synthase as a protective locus against tuberculosis.

Authors:  J D MacMicking; R J North; R LaCourse; J S Mudgett; S K Shah; C F Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

3.  Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice.

Authors:  J L Flynn; M M Goldstein; J Chan; K J Triebold; K Pfeffer; C J Lowenstein; R Schreiber; T W Mak; B R Bloom
Journal:  Immunity       Date:  1995-06       Impact factor: 31.745

4.  Variants in toll-like receptors 2 and 9 influence susceptibility to pulmonary tuberculosis in Caucasians, African-Americans, and West Africans.

Authors:  Digna Rosa Velez; Christian Wejse; Martin E Stryjewski; Eduardo Abbate; William F Hulme; Jamie L Myers; Rosa Estevan; Sara G Patillo; Rikke Olesen; Alessandra Tacconelli; Giorgio Sirugo; John R Gilbert; Carol D Hamilton; William K Scott
Journal:  Hum Genet       Date:  2009-09-22       Impact factor: 4.132

5.  Tuberculosis contact investigations: outcomes in selected areas of the United States, 1999.

Authors:  J Jereb; S C Etkind; O T Joglar; M Moore; Z Taylor
Journal:  Int J Tuberc Lung Dis       Date:  2003-12       Impact factor: 2.373

6.  TLR9 activation is a key event for the maintenance of a mycobacterial antigen-elicited pulmonary granulomatous response.

Authors:  Toshihiro Ito; Matthew Schaller; Cory M Hogaboam; Theodore J Standiford; Stephen W Chensue; Steven L Kunkel
Journal:  Eur J Immunol       Date:  2007-10       Impact factor: 5.532

7.  Quantitative evaluation of T-cell response after specific antigen stimulation in active and latent tuberculosis infection in adults and children.

Authors:  Irene Latorre; Malú De Souza-Galvão; Juan Ruiz-Manzano; Alicia Lacoma; Cristina Prat; Loreto Fuenzalida; Neus Altet; Vicente Ausina; Jose Domínguez
Journal:  Diagn Microbiol Infect Dis       Date:  2009-11       Impact factor: 2.803

8.  Toll-like receptor 4-defective C3H/HeJ mice are not more susceptible than other C3H substrains to infection with Mycobacterium tuberculosis.

Authors:  Arati B Kamath; Jennifer Alt; Hajer Debbabi; Samuel M Behar
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

9.  Normal chest radiography in pulmonary tuberculosis: implications for obtaining respiratory specimen cultures.

Authors:  T Pepper; P Joseph; C Mwenya; G-S McKee; A Haushalter; A Carter; J Warkentin; D W Haas; T R Sterling
Journal:  Int J Tuberc Lung Dis       Date:  2008-04       Impact factor: 2.373

10.  A critical role for CD8 T cells in a nonhuman primate model of tuberculosis.

Authors:  Crystal Y Chen; Dan Huang; Richard C Wang; Ling Shen; Gucheng Zeng; Shuyun Yao; Yun Shen; Lisa Halliday; Jeff Fortman; Milton McAllister; Jim Estep; Robert Hunt; Daphne Vasconcelos; George Du; Steven A Porcelli; Michelle H Larsen; William R Jacobs; Barton F Haynes; Norman L Letvin; Zheng W Chen
Journal:  PLoS Pathog       Date:  2009-04-17       Impact factor: 6.823

View more
  182 in total

Review 1.  Immunomodulation by vitamin D: implications for TB.

Authors:  Rene F Chun; John S Adams; Martin Hewison
Journal:  Expert Rev Clin Pharmacol       Date:  2011-09       Impact factor: 5.045

Review 2.  The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic use.

Authors:  Pin-Yu Perera; Jack H Lichy; Thomas A Waldmann; Liyanage P Perera
Journal:  Microbes Infect       Date:  2011-10-25       Impact factor: 2.700

Review 3.  Striking the right immunological balance prevents progression of tuberculosis.

Authors:  Shachi Pranjal Vyas; Ritobrata Goswami
Journal:  Inflamm Res       Date:  2017-07-15       Impact factor: 4.575

4.  In silico models of M. tuberculosis infection provide a route to new therapies.

Authors:  Jennifer J Linderman; Denise E Kirschner
Journal:  Drug Discov Today Dis Models       Date:  2014-05-09

Review 5.  Latent tuberculosis: what the host "sees"?

Authors:  Hannah P Gideon; JoAnne L Flynn
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

Review 6.  Heterogeneity in tuberculosis.

Authors:  Anthony M Cadena; Sarah M Fortune; JoAnne L Flynn
Journal:  Nat Rev Immunol       Date:  2017-07-24       Impact factor: 53.106

Review 7.  Toward a unified biosignature for tuberculosis.

Authors:  Jeroen Maertzdorf; Stefan H E Kaufmann; January Weiner
Journal:  Cold Spring Harb Perspect Med       Date:  2014-10-23       Impact factor: 6.915

Review 8.  Tuberculosis vaccine types and timings.

Authors:  Ian M Orme
Journal:  Clin Vaccine Immunol       Date:  2014-12-24

9.  Characterization of a novel necrotic granuloma model of latent tuberculosis infection and reactivation in mice.

Authors:  Noton K Dutta; Peter B Illei; Sanjay K Jain; Petros C Karakousis
Journal:  Am J Pathol       Date:  2014-05-09       Impact factor: 4.307

10.  Expression of proinflammatory and regulatory cytokines via NF-κB and MAPK-dependent and IFN regulatory factor-3-independent mechanisms in human primary monocytes infected by Mycobacterium tuberculosis.

Authors:  Elena Giacomini; Maria Elena Remoli; Marta Scandurra; Valérie Gafa; Manuela Pardini; Lanfranco Fattorini; Eliana M Coccia
Journal:  Clin Dev Immunol       Date:  2010-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.